Research Age-Related Macular Degeneration (AMD)
When Anne Lynch, MD, MSPH, professor and director of the Division of Ophthalmic Epidemiology in the University of Colorado Department of Ophthalmology, wanted to recruit more patients with early and intermediate age-related macular degeneration for research, she and a team of researchers turned to social media to engage the community.
Kara Mason | 
May 23, 2023
Research Education Mental Health
Faculty in the University of Colorado Department of Ophthalmology are working to prevent physician burnout before it even begins through a new resident wellness program.
Kara Mason | May 08, 2023
Research Clinical Research Cornea Fuchs' dystrophy
A newer technique for preparing corneal tissue for transplantation has been shown to be safe and effective, while providing a faster and smoother process than the traditional technique, according to researchers in the Department of Ophthalmology at University of Colorado School of Medicine.
Toni Lapp | January 18, 2023
Research Mental Health Low Vision Rehabilitation Age-Related Macular Degeneration (AMD)
Researchers in the Division of Ophthalmic Epidemiology in the University of Colorado Department of Ophthalmology have confirmed an association between vision loss from advanced age-related macular degeneration (AMD) with depression, following a study of patient data collected over seven years. This finding will help bring visibility into the impact of the disease, which is a leading cause of vision loss for older adults.
Toni Lapp | November 10, 2022
Research Cornea Retina Diabetic retinopathy
The state of modern AI is really exciting for health care. With increasing computing capabilities and access to vast datasets, new algorithms are being developed every day. In that sense, the technology has arrived, but there are many remaining challenges in implementing AI in clinical settings.
Toni Lapp | November 01, 2022
Research Age-Related Macular Degeneration (AMD) Retina
Generating retinas from stem cells and transplant technologies to restore human sight felt like just a dream for Valeria Canto-Soler, PhD, associate professor of ophthalmology in the University of Colorado School of Medicine. When she joined the CU Department of Ophthalmology faculty in 2017, she signed on as the inaugural director of CellSight, the department’s ocular stem cell and regeneration research program, setting benchmarks 15 years in the future.
Rachel Wittel | September 12, 2022
The National Eye Institute (NEI) has awarded a $5 million grant to Tianjing Li, PhD, associate professor of ophthalmology at the University of Colorado School of Medicine, in a continuation of the NEI’s support of the Cochrane Eyes and Vision US Satellite (CEV US Satellite) at the Sue Anschutz-Rodgers Eye Center.
Toni Lapp | September 06, 2022
The University of Colorado Department of Ophthalmology’s ocular stem cell and regeneration research program, CellSight, was awarded the top two prizes in the National Eye Institute’s 3D Retinal Organoid Challenge (NEI 3D ROC). The NEI, part of the National Institutes of Health, launched the three-phase challenge in 2017 to stimulate research using retina organoids. These organoids are similar to human retinas but are grown in a lab from stem cells, enabling researchers to study eye diseases and treatments noninvasively.
Toni Lapp | September 01, 2022
Research Neuro-Ophthalmology Retina Awards
A $200,000 grant from the University of Colorado School of Medicine's Program to Advance Physician Scientists and Translational Research (CU ASPIRE) will support researchers to develop new, targeted therapies for those who have experienced vision loss following traumatic brain injuries.
Toni Lapp | August 24, 2022
Research Advancement Pediatric Ophthalmology
Emily McCourt, MD, chief of pediatric ophthalmology at the Sue Anschutz-Rodgers Eye Center and Children’s Hospital Colorado, has been named the inaugural Ponzio Family Chair for Pediatric Ophthalmology at Children’s Colorado.
Toni Lapp | August 10, 2022
Procedures to alleviate eye pressure associated with blinding diseases such as glaucoma date back over a century. Although glaucoma, a condition that damages the eye’s optic nerve, allows for a number of treatment options prior to surgery, including drops and lasers, research has shown traditional surgical techniques could result in higher risks of vision complications, longer recovery times, and higher associated costs. Identifying this disconnect, Malik Y. Kahook, MD, professor of ophthalmology and the Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine, sought out a more accessible and practical solution to propel glaucoma treatment into the 21st century.
Rachel Wittel | January 31, 2022
Research Patient Care Awareness
For more than a decade, Tom Poindexter managed his glaucoma with drops as routinely as brushing his teeth. Catching it early, he was diagnosed with open-angle glaucoma, the most common form, in his 50s.
Rachel Wittel | January 14, 2022
Ophthalmology Times
May 04, 2023
CU Department of Ophthalmology Professor Prem Subramanian, MD, PhD, discusses a double-masked randomized placebo controlled trial of the use of TEPEZZA in patients with a much longer duration of thyroid eye disease than those who are enrolled in the phase 2 and phase 3 studies that lead to FDA approval.
SPIE
April 28, 2023
Researchers, including the Department of Ophthalmology's Jayashree Kalpathy-Cramer, examine how artificial intelligence and machine learning (AI/ML) in medical imaging provide important methods for leveraging large amounts of data to build models to detect disease and provide diagnosis, prognosis, and risk assessment tools to support decision-making in medicine.
The Royal Australian and New Zealand College of Ophthalmologists
April 27, 2023
The University of Colorado Ophthalmology Social Media Research Group, led by Anne Lynch, MD, publishes a Letter to the Editor in the Retinal Issue of Clinical and Experimental Ophthalmology
Science Direct
April 26, 2023
Today, eye cosmetics, or makeup, comprise a diverse array of products. They include concealers, conditioners, creams, extensions, eyeliners, foundations, glues, mascaras, primers, removers, serums, shadows, and toners. A number of the ingredients in these products may be harmful to the ocular surface and adnexa.
